Cannabis Stocks

Is Tilray's $2B Valuation Just The Beginning? Analyst Sees $10B Market Opportunity, Initiates Coverage
Cannabis Vs. Coca-Cola And Marlboro: Marijuana Market Growth Outpaces Alcohol, Tobacco And CPG Giants
Why The Time To Invest In U.S. Cannabis Stocks Is Right Now
Cannabis Vs. Coca-Cola And Marlboro: Marijuana Market Growth Outpaces Alcohol, Tobacco And CPG Giants
Why The Time To Invest In U.S. Cannabis Stocks Is Right Now
Green Thumb Industries' Annual General Meeting, Elects Directors And Approves Executive Compensation
These States Could Go Fully Legal Soon & This Cannabis Company Could Win Big: A Top Stock Pick Trading Below Peers

Cannabis Stocks Recent News

Piper Sandler Maintains Underweight On Canopy Growth Stock, Calls Cannabis Rescheduling 'Largely Symbolic'
A recent company note from Piper Sandler & Co, by senior analysts Michael S.
Top Ohio Cannabis Companies: Analyst Look At Stocks With Potential Market Cap Gains
How will Ohio's cannabis market shape up as it transitions to adult-use recreational sales? Senior analyst Pablo Zuanic outlines in his recent report the potential growth and value creation for state multi-state operators (MSOs).
California Cannabis Company Exceeds Sales Expectations, Boosts Production To Improve Margins And Enhance Brands
California-based cannabis company Gold Flora (OTC: GRAMF) has reported significant developments in its first-quarter results for 2024. Exceeding sales projections, Gold Flora's retail revenue rose by 6%, while wholesale revenue jumped 72%.
TILT Holdings' Cannabis Sales Steady Despite Supply Disruptions, Are Debt And Stock Dilution Posing Risks?
Vape Hardware Business Impacted
$514M Tax Breaks Await This Marijuana Company With Rescheduling, Market Cap Set To Soar
Jushi Holdings Inc. (OTC: JUSHF) is poised for substantial growth with potential adult-use cannabis legalization in Ohio and Pennsylvania as well as continuous expansion in Virginia’s medical market.
Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%
According to a recent report by Pablo Zuanic of Zuanic & Associates, MariMed (OTC: MRMD) a multi-state cannabis operator (MSO) is positioned for significant stock gains.
Florida's Marijuana Market Could Drive 139% Revenue Spike For Planet 13, Fourfold Market Cap Growth
Planet 13 Holdings (OTC: PLNH) has completed its acquisition of VidaCann, reporting $12.5 million in sales for the first quarter of 2024, a 56%
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to the fluidity of water. Why is this important for cannabis stocks?
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms International —present potential investment opportunities.
Cannabis Stocks Rallied After Rescheduling News, Investment Management Firm Co-Founder Discusses Impact And Next Steps
Explore how DOJ's cannabis rescheduling boosts stocks and insights from Emily Paxhia on the industry's future. Read now!
Glass House Cannabis Brands Exceeds Q1 2024 Guidance In Cash, Sales, Production And EBITDA
Glass House Brands Inc. (OTC: GHBWF) reported financial results for Q1 2024 with a revenue of $30.1 million, a 9% increase year-over-year. Biomass production reached 61,334 pounds, a 28% increase from the previous year, despite no expansion in cultivation footprint.
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legislative changes on its operations.
Q1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross Margin
MariMed Inc. (MRMD), a multi-state cannabis operator, disclosed its financial outcomes Wednesday evening for the first quarter of 2024, which ended on March 31. The company reported a revenue of $37.9 million, an increase from $34.4 million in the corresponding quarter last year.
Post Cannabis Rescheduling: What's Next For Marijuana Giants? Potential $1.1B Cash Flow Boost From IRS 280E Removal
Following the recent move on the part of the DEA toward 
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and one day, interstate commerce." That's according to Benzinga's cannabis stock expert, Michael Berger, who is on a mission to uncover the most promising marijuana stocks poised for growth, even in a dull market.
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs).
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move
How Big Caps Rewrite Valuation Rules In Cannabis: Cash Puzzle For Companies Above And Below $500M
How do we look at cannabis companies' cash flow? What is their total value and what methods are used to assess their worth?
Investors Shuffle Stock Positions In Aurora Cannabis: Beyond Earnings, Liquidity Looks Appealing
Aurora Cannabis Inc. captured investor attention with a dramatic 38% increase in options trading and a significant 18.2% surge in stock price in a single trading day. These movements underscore a robust financial period for the company, which reported quarterly revenues of $53.34 million, surpassing expectations by nearly 16%.
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
In the first quarter of 2024, the cannabis sector faces a mixed economic landscape with a notable sequential decline in sales across several states.
Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability
A recent report by Viridian Capital Advisors explores the valuation and growth prospects of cannabis stocks against those of well-established sectors like alco
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.